Clinical Study
Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years
Table 3
Microbiologic laboratory data.
| Pathogens | Number (%) of episodes |
| Methicillin-sensitive Staphylococcus aureus | 19 (11.5%) | Methicillin-resistant Staphylococcus aureus | 15 (9.1%) | Coagulase-negative staphylococci | 36 (21.9%) |
| Gram-negative bacilli | | Escherichia coli | 7 (4.2%) | Pseudomonas aeruginosa | 4 (2.4%) | Klebsiella pneumoniae | 3 (1.8%) | Salmonella | 2 (1.2%) | Serratia marcescens | 2 (1.2%) | Morganella morganii | 1 (0.6%) | Aeromonas hydrophila | 1 (0.6%) | Acinetobacter baumannii | 1 (0.6%) |
| Anaerobes | | Peptostreptococcus | 4 (2.4%) | Enterococcus faecalis | 4 (2.4%) | Propionibacterium acnes | 3 (1.8%) |
| β-streptococcus group B | 3 (1.8%) | Viridans streptococcus | 3 (1.8%) | Streptococcus pneumoniae | 1 (0.6%) | Staphylococcus epidermidis | 1 (0.6%) | Mycobacterium tuberculosis complex | 1 (0.6%) | No growth | 46 (29.3%) |
|
|